Updated: January 1, 2026
Why Is Calcium Acetate So Hard to Find? [Explained for 2026]
Author
Peter Daggett

- What Is Calcium Acetate Used For?
- Is There a Calcium Acetate Shortage in 2026?
- Why Do Pharmacies Run Out of Calcium Acetate?
- Who Needs Calcium Acetate and Why Can't They Just Skip a Day?
- What Should You Do If Your Pharmacy Is Out?
- Are Brand-Name Versions Harder to Find?
- What About the Liquid Form (Phoslyra)?
- How to Be Proactive About Your Supply
- The Bottom Line
Overview
Struggling to find calcium acetate (PhosLo, Eliphos) at your pharmacy? Here's why it can be hard to locate and what you can do about it.
Is Calcium Acetate in stock near you?
Medfinder checks real pharmacy inventory — start a search and we'll find Calcium Acetate near you.
If you or a loved one is on dialysis and takes calcium acetate (brand names PhosLo, Phoslyra, Eliphos, or Calphron) to control high phosphate levels, you may have noticed that it is not always easy to find. While calcium acetate is not in a declared FDA shortage, patients and caregivers across the country regularly run into empty shelves, back-order notices, and confused pharmacy staff. So what is really going on?
What Is Calcium Acetate Used For?
Calcium acetate is a phosphate binder prescribed to dialysis patients with end-stage renal disease (ESRD). When the kidneys fail, they can no longer filter excess phosphate out of the blood. High phosphate levels — a condition called hyperphosphatemia — can cause weak bones, calcium deposits in blood vessels, and dangerous heart problems.
Calcium acetate is taken with every meal. It binds to the phosphate in food before the body can absorb it, so the phosphate is eliminated in the stool instead of entering the bloodstream. Patients typically take 2 to 4 tablets or capsules per meal, meaning a single patient may need 6 to 12 doses per day. That adds up to a high volume of pills that must be refilled frequently.
Check live stock now.
Is There a Calcium Acetate Shortage in 2026?
As of 2026, there is no active FDA-declared nationwide shortage of calcium acetate. The generic version is manufactured by multiple companies and is available at major pharmacy chains. However, that does not mean every pharmacy near you will have it in stock at all times.
The availability gap is largely a distribution and stocking issue, not a manufacturing crisis. Smaller independent pharmacies, rural locations, and even some big-box chains may not stock calcium acetate consistently — particularly the liquid form (Phoslyra) or specific brand-name versions like Eliphos.
Why Do Pharmacies Run Out of Calcium Acetate?
There are several reasons why your pharmacy may not have calcium acetate when you need it:
High pill volume per patient. Each dialysis patient may use 180 to 360 tablets per month. Pharmacies serving dialysis centers need large, consistent stock.
Brand vs. generic inconsistency. Your insurance or prescription may call for a specific brand (e.g., PhosLo) that a particular pharmacy does not carry, even if the generic is available.
Liquid formulation scarcity. The oral solution (Phoslyra, 667 mg/5 mL) is prescribed for patients who cannot swallow capsules, but many pharmacies do not stock it at all. You may need to order it in advance.
Regional distributor delays. Even if no national shortage exists, localized supply chain hiccups can create temporary gaps at the regional or state level.
Low-priority stocking. Some pharmacies de-prioritize medications that have slow local demand, choosing not to hold the inventory unless patients are actively requesting it.
Who Needs Calcium Acetate and Why Can't They Just Skip a Day?
Calcium acetate is not a medication patients can easily take a break from. Missing doses means dietary phosphate goes unbound and gets absorbed into the bloodstream. For dialysis patients, this can quickly cause dangerous phosphate spikes — even a few days without the medication can push phosphate levels into a range that causes symptoms like bone pain, itching, heart rhythm problems, and soft tissue calcification.
This is what makes the availability problem so serious. It is not a lifestyle medication. It is a daily necessity for many dialysis patients, and going without it for even a short time is medically risky.
What Should You Do If Your Pharmacy Is Out?
Here are the most effective steps to take immediately:
Call multiple pharmacies. Do not assume the generic will be in stock everywhere. Call at least 5–10 pharmacies in your area before concluding that it is unavailable locally.
Ask about equivalent generics. If PhosLo is out, ask whether the pharmacy carries calcium acetate under a different manufacturer's label or generic packaging.
Contact your dialysis center. Many dialysis centers have relationships with specialty pharmacies that stock phosphate binders reliably. Your care team may be able to direct you to one.
Use medfinder.
is a paid service that calls pharmacies near you to check which ones actually have your medication in stock. Instead of spending hours on hold, you get your results texted directly to you.
Talk to your nephrologist about alternatives. If you truly cannot find calcium acetate, your doctor may temporarily switch you to sevelamer carbonate (Renvela) or another phosphate binder while you locate a supply. Do not make this change without medical guidance.
Are Brand-Name Versions Harder to Find?
Yes. Brand-name formulations like PhosLo and Eliphos are stocked by fewer pharmacies than the generic. If your prescription is written for a specific brand, you may have a harder time filling it at a standard retail pharmacy. Ask your nephrologist whether a generic substitution is acceptable — for most patients, the generic 667 mg capsule or tablet works identically.
Found
Rate
on average
What About the Liquid Form (Phoslyra)?
The oral solution (Phoslyra, 667 mg/5 mL) is the hardest form to find. It is primarily prescribed for patients who have trouble swallowing, and it is not stocked at most retail pharmacies. If you take the liquid form, plan ahead by at least a week and ask your pharmacy to special order it. Mail-order pharmacy options through your insurance's Part D plan may also be able to supply it more reliably.
How to Be Proactive About Your Supply
The best defense against running out of calcium acetate is planning ahead:
Refill your prescription when you have 7–10 days left, not when you run out.
Ask your pharmacy to set an automatic refill so your supply is always ready.
Consider switching to a 90-day supply through mail order, which reduces the risk of running out between fills.
Keep a backup contact list of pharmacies that have carried it before.
The Bottom Line
Calcium acetate is not in a declared national shortage, but it can still be surprisingly difficult to find at your local pharmacy — especially in liquid form or as a specific brand. The key is to act early, call ahead, and have a plan B. Read more about how to find calcium acetate in stock near you or explore alternatives to calcium acetate if you cannot fill your prescription.
Frequently Asked Questions
As of 2026, calcium acetate does not have an active FDA-declared shortage. The generic is manufactured by multiple companies and is broadly available at major pharmacy chains. However, individual pharmacies — especially smaller or rural ones — may periodically run low on stock, particularly for brand-name versions like PhosLo or the liquid formulation Phoslyra.
Calcium acetate may be out of stock because of high pill volume per patient (dialysis patients take 6–12 doses per day), inconsistent local stocking, or temporary distributor delays. Brand-name versions like Eliphos and PhosLo are stocked by fewer pharmacies than the generic. Try calling multiple pharmacies or asking your dialysis center for a referral to a specialty pharmacy.
No. Calcium acetate is a medically necessary medication for dialysis patients. Missing doses allows dietary phosphate to enter the bloodstream, which can quickly cause dangerous spikes in phosphate levels. If your pharmacy is out, contact your nephrologist immediately to discuss your options, including temporarily switching to another phosphate binder.
Yes. PhosLo is a brand-name version of calcium acetate 667 mg. The generic is therapeutically equivalent and is often much less expensive. If your prescription is written for PhosLo, ask your nephrologist whether a generic substitution is acceptable — for most patients it works identically.
medfinder is a paid service that contacts pharmacies near you to check which ones have your medication in stock. You provide your medication, dosage, and location, and medfinder calls pharmacies on your behalf. Results are texted directly to you, saving you hours of calling pharmacies yourself.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Calcium Acetate also looked for:
More about Calcium Acetate
38,179 have already found their meds with Medfinder.
Start your search today.
Your information is private and never shared.





